Denticulatain B exhibits significant potential in pharmaceutical applications, particularly in anti-inflammatory and neuroprotective therapies. Studies suggest it may modulate cellular pathways involved in oxidative stress, making it a candidate for research in neurodegenerative conditions such as Alzheimer's and Parkinson’s disease. Its natural origin and bioactivity also support exploration in developing plant-based medicinal compounds. Additionally, it has shown antimicrobial properties against select pathogenic strains, indicating possible use in antimicrobial formulations. Research is ongoing to evaluate its efficacy and safety for therapeutic use.